What is NDC 0187-2098?

0187-2098 is the product NDC for Arazlo (tazarotene), Tazarotene .45 mg/g lotion, listed with the FDA by Bausch Health US, LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.

Bausch Health US, LLC, NDC labeler code 0187. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Arazlo?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Arazlo NDC 0187-2098 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)0187-2098Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00187-2098Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0187-2098-10	0018720981000187209810	10 TUBE in 1 CARTON (0187-2098-10) / 3 g in 1 TUBE (0187-2098-03)Marketed from Dec 19, 2019 · Sample package
0187-2098-45	0018720984500187209845	1 TUBE in 1 CARTON (0187-2098-45) / 45 g in 1 TUBEMarketed from Dec 19, 2019

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Arazlo
Generic name (nonproprietary): tazarotene
Active ingredients: Tazarotene — .45 mg/g
Dosage form: Lotion
Route: Topical
Labeler: Bausch Health US, LLCNDC labeler code 0187
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 211882
Marketing start: Dec 19, 2019
Listing expires: Dec 31, 2026
Other FDA classes: Retinoids (Chemical structure)
Identifiers: Product ID 0187-2098_06456968-fe83-2c27-e063-6294a90af3eaSPL ID 06456968-fe83-2c27-e063-6294a90af3eaSPL set ID d941ff25-c221-4a55-8012-0dcf3bbcbbd1RxCUI 2267561, 2267566UNII 81BDR9Y8PS
Pharmacologic class: Retinoid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400187209810 followed by a unit qualifier and the quantity

Package 00187-2098-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Sep 26, 2023.

Indications (excerpt from the label)

ARAZLO ® (tazarotene) lotion, 0.045% is indicated for the topical treatment of acne vulgaris in patients 9 years of age and older. ARAZLO is a retinoid indicated for the topical treatment of acne vulgaris in patients 9 years of age and older. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0187-2098

What is NDC 0187-2098?: 0187-2098 is the product NDC for Arazlo (tazarotene), Tazarotene .45 mg/g lotion, listed with the FDA by Bausch Health US, LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Arazlo (Tazarotene).
What is the active ingredient?: Tazarotene.
Who is the labeler?: Bausch Health US, LLC, NDC labeler code 0187. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Arazlo?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Arazlo (Tazarotene) NDC 0187-2098